Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/13/2012US20120232088 Piperazinedione compounds
09/13/2012US20120232087 Methods and compositions for treating solid tumors and other malignancies
09/13/2012US20120232086 FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY
09/13/2012US20120232085 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/13/2012US20120232084 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
09/13/2012US20120232083 Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/2012US20120232082 Novel compounds and therapeutic use thereof for protein kinase inhibition
09/13/2012US20120232081 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
09/13/2012US20120232080 Phenoxy acetic acids as ppar delta activators
09/13/2012US20120232079 Novel acylpiperazinones and their use as pharmaceuticals
09/13/2012US20120232078 Novel Medicaments
09/13/2012US20120232077 Selective antibacterials for clostridium difficile infections
09/13/2012US20120232076 Quinolizidinone carboxamide m1 receptor positive allosteric modulators
09/13/2012US20120232075 Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
09/13/2012US20120232074 Imidazo [4, 5-C] Quinoline Derivatives As Bromodomain Inhibitors
09/13/2012US20120232073 Fused bicyclic pyrimidine derivatives and methods of use thereof
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232070 Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease
09/13/2012US20120232069 Process for preparing efavirenz polymorph
09/13/2012US20120232068 Quinazolines as potassium ion channel inhibitors
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232066 Compositions for reducing risk of adverse events caused by drug-drug interactions
09/13/2012US20120232065 Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them
09/13/2012US20120232064 Aspartyl protease inhibitors
09/13/2012US20120232063 2-Aminoindole Compounds And Methods For The Treatment Of Malaria
09/13/2012US20120232062 Azaindazoles to treat flaviviridae virus infection
09/13/2012US20120232061 Novel compounds
09/13/2012US20120232060 Modified release preparations containing oxcarbazepine and derivatives thereof
09/13/2012US20120232059 Modulators of ATP-Binding Cassette Transporters
09/13/2012US20120232058 Substituted pyridine derivatives and their medical use
09/13/2012US20120232057 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
09/13/2012US20120232056 Heterocyclic compounds for the inhibition of pask
09/13/2012US20120232055 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/13/2012US20120232054 Pyrrolotriazine compounds
09/13/2012US20120232053 Quaternary ammonium compounds useful as muscarinic receptor antagonists
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
09/13/2012US20120232051 3-amino-pyridines as gpbar1 agonists
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120232049 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
09/13/2012US20120232048 Method for modulating gpr119 g protein-coupled receptor and selected compounds
09/13/2012US20120232047 Substituted clavulanic acid
09/13/2012US20120232046 Method and kit for reducing the symptoms of peripheral vascular disease
09/13/2012US20120232045 Methods and systems for prognosis of a patient's response to treatment of androgenetic skin disorders
09/13/2012US20120232044 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
09/13/2012US20120232043 Lubiprostone for obstetrical or gynecological applications
09/13/2012US20120232042 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
09/13/2012US20120232041 Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia
09/13/2012US20120232040 Medication for clinical extensively-drug resistant acinetobacter baumannii
09/13/2012US20120232039 Primary amine diazeniumdiolate heterocyclic derivatives
09/13/2012US20120232038 Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate
09/13/2012US20120232037 Treatment of obesity, metabolic syndrome, and diabetes with protein kinase c inhibitors
09/13/2012US20120232036 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
09/13/2012US20120232035 Bicyclic pyrimidinones and uses thereof
09/13/2012US20120232034 Vesicular formulations
09/13/2012US20120232033 Amines or amino alcohols as glyt1 inhibitors
09/13/2012US20120232032 Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material
09/13/2012US20120232031 Injectable formulations for intra-articular or peri-articular administration
09/13/2012US20120232030 Heat stable hyaluronic acid compositions for dermatological use
09/13/2012US20120232029 2',4'-substituted nucleosides as antiviral agents
09/13/2012US20120232028 Bicyclic Compound, Production and Use Thereof
09/13/2012US20120232027 Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel
09/13/2012US20120232026 Spirocyclic isoxazoline derivatives as antiparasitic agents
09/13/2012US20120232025 Safener drug combinations for use with nmda antagonist drugs
09/13/2012US20120232019 Compositions and Methods for Treatment of Eye Disorders
09/13/2012US20120232018 Polycarbonates for delivery of drugs and methods of preparation thereof
09/13/2012US20120232011 Use of Rapamycin and Rapamycin Derivatives for the Treatment of Bone Loss
09/13/2012US20120232006 Production of polyurethane foams
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120232003 Compositions and methods for diabetes treatment
09/13/2012US20120232000 Methods and compositions for promoting regeneration by increasing intracellular sodium concentration
09/13/2012US20120231995 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
09/13/2012US20120231993 NEW SYNTHETIC ROUTE FOR THE PREPARATION OF ALPHA-AMINO BORONIC ACID DERIVATIVES via SUBSTITUTED ALK-1-YNES
09/13/2012US20120231097 Medicinal composition and usage
09/13/2012US20120231095 Agents derived from holoptelea integrifolia and their compositions for the control of metabolic syndrome and associated diseases
09/13/2012US20120231093 Method for preparing nano-scale or amorphous particle using solid fat as a solvent
09/13/2012US20120231092 Combination Therapy for Bipolar Disorder
09/13/2012US20120231090 Molecular biomarker set for early detection of ovarian cancer
09/13/2012US20120231089 Reversing autonomic nervous system dysfunction by potentiating methylation
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
09/13/2012US20120231084 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
09/13/2012US20120231083 Sustained release cannabinoid medicaments
09/13/2012US20120231082 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
09/13/2012US20120231081 Controlled release dosage forms
09/13/2012US20120231080 Controlled release dosage forms
09/13/2012US20120231079 Methods and compositions for controlled delivery of phytochemical agents
09/13/2012US20120231078 Method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
09/13/2012US20120231077 Coated Tablets, Their Method of Preparation, and Related Uses
09/13/2012US20120231076 Pharmaceutical compositions comprising rivaroxaban
09/13/2012US20120231075 Abuse-resistant opioid dosage form
09/13/2012US20120231074 Pharmaceutical solid dosage form
09/13/2012US20120231073 Dexlansoprazole compositions
09/13/2012US20120231072 Thermo-responsive hydrogel compositions
09/13/2012US20120231070 Sustained-release liposomal anesthetic compositions
09/13/2012US20120231068 Virucidal properties of various forms of sophorolipids
09/13/2012US20120231063 Dressing comprising active components of centella asiatica and use of the same
09/13/2012US20120231062 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
09/13/2012US20120231061 Long term drug delivery devices with polyurethane-based polymers and their manufacture
09/13/2012US20120231060 Antimicrobial hydrogels, methods of preparation thereof, and articles therefrom
09/13/2012US20120231054 Use of an oleogel containing triterpene for healing wounds
1 ... 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 ... 7860